OpenAI’s explicit prioritization of AI safety has anchored trader sentiment, with CEO Sam Altman stating in September that a 2026 listing would be ill-advised and the CFO previously signaling a 2027 timeline. The company confidentially filed its S-1 in June but has no public timetable, instead closing a scaled-back private round near $20 billion at a $1.25 trillion valuation as a bridge amid AI-stock volatility and competition for capital from Anthropic’s November IPO. These developments underpin the 97.5% market-implied odds against a 2026 debut, reflecting skin-in-the-game consensus on the company’s stated path. A rapid resolution of safety concerns or sharp improvement in market conditions could still shift timing, though current statements and regulatory preparation point to 2027.